Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025PharmaceuticsOpen Access

Science-Based Risk Assessment for the Categorization of Visual Inspection Defects of Sterile Dosage Forms

View Full Paper
Ask AI
Bookmark
Share

Authors

HMHanns‐Christian MahlerEFEmilien FolzerRARagunath Ananthavettivelu

Discussion

Loading...

Member takes

Overview

This methodology demonstrates a structured approach for classifying visual inspection defects, implying enhanced quality control in sterile products.

Key Points

  • Science-based risk assessment improves defect categorization for sterile dosage forms, enhancing patient safety.
  • Using a modified Failure Mode and Effects Analysis, this approach categorizes defects into critical, major, or minor levels.
  • The methodology aids in visual inspections and AQL checks, ensuring defective units are identified and excluded effectively.
  • Practical applications of the approach were showcased through examples involving vials, pre-filled syringes, and cartridges.

Cite This Study

Mahler et al. (2025) studied this question.

synapsesocial.com/papers/68bb3a352b87ece8dc954e63https://doi.org/10.3390/pharmaceutics17091121
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2024
  2. 2AI-Guided Real-Time Detection of Flow Irregularities and Bottlenecks in Pharmaceutical Vial Filling Lines Using Vision-Based Models2025
  3. 3Machine Vision for Detecting Defects in Liquid Bottles: An Industrial Application for Food and Packaging Sector2024 · 13 citations
  4. 4Development and Evaluation of a Vision Inspection System for Plastic Bottle Measurement2024 · 3 citations
  5. 5Classical Computer Vision for Automated Quality Inspection: A Reproducible Study Integrating SPC and Process Capability2026